Novartis

Swiss-American multinational pharmaceutical corporation

NOVN SIX Swiss · home listing NVS NYSE ISIN CH0012005267 SEC CIK 1114448 LEI 5493007HIVTX6SY6XD66
Follow Novartis Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · IFRS
EPS, diluted -
Revenue by quarter
$12.5B
$14.1B
Q2 24 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income12 fiscal years
  • Revenue
  • Net income
$0$20B$40B$60BFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$54.5B$14B
FY24$50.3B$11.9B
FY23$45.4B$14.9B
FY22$42.2B$7B
FY21$42.8B$24B
FY20$48.7B$8.1B
FY19$47.5B$11.7B
FY18$44.8B$12.6B
FY17$42.4B$7.7B
FY16$48.5B$6.7B
FY15$49.4B$17.8B
FY14--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2578.8%32.4%25.6%
FY2477.3%28.9%23.7%
FY2375.2%21.5%32.7%
FY2275.5%18.8%16.5%
FY2175.4%23.5%56.1%
FY2071.5%20.9%16.6%
FY1972.1%19.1%24.7%
FY1870.5%18.7%28.1%
FY1770.2%20.5%18.2%
FY1665.8%17%13.8%
FY1566.7%18.2%36%
FY14---
Free cash flowOperating cash flow minus capital expenditure
$0$5B$10B$15B$20BFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$17.6B
FY24$16.3B
FY23$13.4B
FY22$13.3B
FY21$14B
FY20$12.4B
FY19$12.2B
FY18$13B
FY17$11.3B
FY16$9.6B
FY15$9.5B
FY14-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$5B$10B$15B$20BFY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$7.8B$9.2B
FY24$7.6B$8.3B
FY23$7.3B$8.7B
FY22$7.5B$10.7B
FY21$7.4B$3.1B
FY20$7B$2.8B
FY19$6.6B$5.5B
FY18$7B$2B
FY17$6.5B$5.5B
FY16$6.5B$1.1B
FY15$6.6B$6.1B
FY14--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Novartis
  • Healthcare median
−100%−50%0%50%100%FY15FY17FY19FY21FY23FY25
Show the numbers
YearNovartisHealthcare median
FY2525.6%−30.6%
FY2423.7%−47%
FY2332.7%−58%
FY2216.5%−80.4%
FY2156.1%−71.9%
FY2016.6%−62.2%
FY1924.7%−46.3%
FY1828.1%−49.6%
FY1718.2%−45.9%
FY1613.8%−36%
FY1536%−38.4%
FY14-−35.5%